SPERO THERAPEUTICS INC (SPRO)       1.83  +0.01 (+0.55%)

1.83  +0.01 (+0.55%)

US84833T1034 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.33 -0.31 -0.02-6.66% Q2 2022 -0.87 -0.95 0.087.96% Q1 2022 -1.01 -0.89 -0.12-13.90% Q4 2021 -0.90 -0.76 -0.14-18.04% Q3 2021 -0.70 -0.68 -0.02-3.46% Q2 2021 -0.63 -0.77 0.1417.76% Q1 2021 -0.66 -0.66 0.00-0.32% Q4 2020 -0.68 -0.76 0.0810.25%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.97 -2.89 31.71%Q4 2022 0.27 -0.90 130.03%FY 2023 -1.22 -1.97 38.24%Q1 2023 -0.35 -1.01 65.66%Q2 2023 -0.40 -0.87 54.28%Q3 2023 -0.55 -0.33 -66.91%Q4 2023 -0.63 0.27 -333.96%FY 2024 -1.14 -1.22 6.69%FY 2025 -2.38 -1.14 -108.97%FY 2026 -2.38 -2.38 0.00%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 2.006M 5.525M -3.519M-63.69% Q2 2022 1.993M 1.173M 820K69.91% Q1 2022 2.069M 2.618M -549K-20.97% Q4 2021 2.744M 5.049M -2.305M-45.65% Q3 2021 3.064M 4.556M -1.492M-32.75% Q2 2021 5.148M 4.616M 532K11.53% Q1 2021 7.3M 3.223M 4.077M126.50% Q4 2020 1.91M 3.745M -1.835M-49.00%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 40.392M 18.256M 121.25%Q4 2022 34.68M 2.744M 1,163.85%FY 2023 27.948M 40.392M -30.81%FY 2024 51M 27.948M 82.48%FY 2025 40.953M 51M -19.70%FY 2026 36.822M 40.953M -10.09%FY 2027 110.77M 36.822M 200.83%FY 2028 180.74M 110.77M 63.17%FY 2029 254.69M 180.74M 40.92%FY 2030 346.29M 254.69M 35.97%